Metropolitan Life Insurance Company (MetLife)’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,664
| Closed | -$16.4K | – | 101 |
|
|
2024
Q1 | $16.4K | Buy |
3,664
+1,941
| +113% | +$8.68K | ﹤0.01% | 1951 |
|
|
2023
Q4 | $5.53K | Sell |
1,723
-2,618
| -60% | -$8.4K | ﹤0.01% | 2281 |
|
|
2023
Q3 | $13.8K | Hold |
4,341
| – | – | ﹤0.01% | 2070 |
|
|
2023
Q2 | $21.6K | Hold |
4,341
| – | – | ﹤0.01% | 1889 |
|
|
2023
Q1 | $21.4K | Sell |
4,341
-1,378
| -24% | -$6.81K | ﹤0.01% | 1854 |
|
|
2022
Q4 | $36K | Buy |
5,719
+1,286
| +29% | +$8.09K | ﹤0.01% | 1678 |
|
|
2022
Q3 | $47.9K | Hold |
4,433
| – | – | ﹤0.01% | 1485 |
|
|
2022
Q2 | $50.5K | Hold |
4,433
| – | – | ﹤0.01% | 1505 |
|
|
2022
Q1 | $40.4K | Sell |
4,433
-13,481
| -75% | -$123K | ﹤0.01% | 1715 |
|
|
2021
Q4 | $267K | Sell |
17,914
-1,136
| -6% | -$16.9K | ﹤0.01% | 1818 |
|
|
2021
Q3 | $490K | Hold |
19,050
| – | – | 0.01% | 1479 |
|
|
2021
Q2 | $497K | Buy |
19,050
+3,686
| +24% | +$96.1K | 0.01% | 1531 |
|
|
2021
Q1 | $542K | Sell |
15,364
-465
| -3% | -$16.4K | 0.01% | 1360 |
|
|
2020
Q4 | $400K | Buy |
15,829
+233
| +1% | +$5.88K | 0.01% | 1505 |
|
|
2020
Q3 | $588K | Buy |
15,596
+711
| +5% | +$26.8K | 0.01% | 1100 |
|
|
2020
Q2 | $637K | Buy |
14,885
+1,856
| +14% | +$79.5K | 0.01% | 1039 |
|
|
2020
Q1 | $253K | Hold |
13,029
| – | – | 0.01% | 1455 |
|
|
2019
Q4 | $338K | Hold |
13,029
| – | – | 0.01% | 1563 |
|
|
2019
Q3 | $355K | Buy |
13,029
+3,040
| +30% | +$82.9K | 0.01% | 1511 |
|
|
2019
Q2 | $268K | Buy |
9,989
+1,227
| +14% | +$32.9K | ﹤0.01% | 1694 |
|
|
2019
Q1 | $253K | Sell |
8,762
-493
| -5% | -$14.3K | ﹤0.01% | 1743 |
|
|
2018
Q4 | $249K | Buy |
+9,255
| New | +$249K | 0.01% | 1656 |
|